Dr. Larry Corey underscored that implementation of vaccines is important.
Dr. Steve Pergam gave practical guidance for managing risk of infection as an immunocompromised person.
Dr. Larry Corey joined Jake Whittenberg for a bike ride and then sat down to discuss lessons learned during COVID.
Highlights from Dr. Anthony Fauci and Dr. Larry Corey’s fireside chat was covered as well as the presentation of the honorary Hutch Award.
Dr. Larry Corey compared the challenge of developing effective HIV vaccines with raising children.
Dr. Catherine Liu and Rebecca Relyea, a patient, discussed a monoclonal antibody drug that prevents COVID in people who are immunocompromised.
Drs. Josh Schiffer and Trevor Bedford shared COVID-19 insights.
Dr. Josh Schiffer reflected on the evolving nature of the pandemic.
Dr. Larry Corey commented on longer-term immune data on the J&J COVID vaccine.
Dr. Josh Schiffer recommended a flexible approach to SARS-CoV-2 measures going forward.
Drs. Josh Schiffer, Pavitra Roychoudhury and Trevor Bedford shared omicron insights.
Drs. Elizabeth Halloran and Larry Corey described decades of scientific effort that led to COVID vaccines.
Dr. Josh Schiffer compared omicron to previous variants.
Dr. Larry Corey highlighted the strain on hospital systems.
Dr. Josh Schiffer characterized recent COVID variants.
Dr. Larry Corey talked about the complexity of COVID, quarantines and young children.
Dr. Josh Schiffer described his concerns about omicron infections.
Dr. Larry Corey answered viewer questions about omicron, including vaccine efficacy.
Drs. Larry Corey and Pavitra Roycoudhury discussed the Omicron variant.
Dr. Josh Schiffer noted that larger data sets are needed to understand omicron.
Dr. Larry Corey reflected on how COVID will change our response to respiratory illnesses.
Dr. Larry Corey commented on measures enacted to fight COVID-19.
Dr. Larry Corey reflected on the FDA’s approval of Pfizer’s COVID vaccine in children.
Dr. Larry Corey discussed when 5-11 year olds may receive the vaccine.
Dr. Josh Schiffer discussed implications for immunity against COVID-19 as SARS-CoV-2 continues to mutate.
Dr. Larry Corey underscored the safety of COVID vaccines.
Dr. Larry Corey commented on COVID vaccine boosters.
Dr. Larry Corey noted that vaccine boosters may prevent transmission.
Dr. Larry Corey characterized results from an HIV vaccine study he helped lead.
Dr. Steve Pergam and Elizabeth Krantz discussed their study on cancer patients and immunity to measles and mumps.
Dr. Larry Corey discussed COVID vaccine boosters.
Dr. Larry Corey discussed breakthrough cases of COVID.
Dr. Josh Schiffer discussed the rise of variants.
Dr. Steve Pergam and Elizabeth Krantz discussed their study on measles and mumps immunity in cancer patients.
Dr. Steven Pergam and biostatistician Elizabeth Krantz discussed their research on cancer patients and immunity to mumps and measles.
Dr. Larry Corey commented on COVID vaccines in immunocompromised people.
Dr. Larry Corey expressed concern about using partial doses of COVID vaccines to increase global access to the vaccines without clinical data.
Dr. Larry Corey shared his reflections on the COVID vaccine program.
Dr. Larry Corey commented on a study that is testing whether the Moderna COVID-19 vaccine works to prevent infection and transmission of the virus.
Dr. Larry Corey gave context around COVID vaccine efficacy and durability. He said, “If the duration of protection is such that you can still get a mild cold, but you don't end up in the hospital, the vaccine will still be a success.”
Drs. Josh Hill and Steve Pergam discussed COVID immunity among immunocompromised people. Dr. Hill pointed out that for those with weakened immune systems, “Antibody tests are just the tip of the iceberg of what the immune system is doing.”
Dr. Josh Hill emphasized how broad COVID vaccination can “protect our vulnerable patient populations within the community who either can’t get vaccinated for some reason, or who may not have as good of a vaccine response.”
Dr. Josh Schiffer stressed rapid vaccination.
Drs. Tony Fauci and Larry Corey reflected on their collaboration on HIV and COVID vaccines.
Dr. Larry Corey commented on the challenge of creating an effective HIV vaccine.
Dr. Larry Corey explained one of the questions the Prevent COVID U study is designed to answer:
Drs. Keith Jerome and Martine Aubert won the annual STAT Madness contest for biomedical research.
In a Q&A, Dr. Steve Pergam discussed national guidelines on COVID vaccines in cancer patients.
Dr. Josh Schiffer explained his team’s latest analysis of how super-spreader events allow variants to become predominant and create new variants.
Dr. Larry Corey discussed a new study to find out if COVID vaccines prevent transmission.
Dr. Larry Corey characterized results from the Antibody Mediated Prevention studies, coordinated through the HIV Vaccine Trials Network, as “important proof of concept” in using antibody infusions to prevent HIV.
Dr. Steve Pergam reflected on how public health measures helped reduce spread of other respiratory viruses.
Dr. Josh Schiffer discussed his computational modeling of COVID-19 and a potential fourth wave of infections.
Drs. Larry Corey, Josh Schiffer and Trevor Bedford spoke with The Seattle Times about herd immunity.
Dr. Josh Schiffer provided context on how the new coronavirus variants makes modeling difficult.
Dr. Josh Hill cautioned that high school sports may be disrupted by COVID-19.
Drs. Steve Pergam and Michele Andrasik stressed the need for more diversity and inclusion in vaccine clinical trials.
Dr. Larry Corey gave his thoughts to Business Insider about SARS-CoV-2 becoming endemic.
In an op-ed, Dr. Josh Schiffer advocated for increased masking to limit the COVID-19 pandemic.
Dr. Larry Corey gave his insight on the pause in rolling out the AstraZeneca vaccine in South Africa.
Dr. Steve Pergam explained why people should get their COVID-19 vaccines from the same provider.
Dr. Larry Corey was quoted in The Washington Post on the potential for reinfection from some variants.
Dr. Josh Schiffer shared his prediction of what the next wave of the coronavirus pandemic could look like.
Dr. Catherine Liu commented on emerging recommendations for cancer patients receiving COVID-19 vaccines.
Dr. Larry Corey reflected on results from the Antibody Mediated Prevention study.
Dr. Larry Corey discussed the global significance of the upcoming Janssen vaccine trial results.
Dr. Larry Corey stressed that to slow the spread of variants of concern, as we expand access to COVID-19 vaccines, “We have to do everything we can to decrease the risk of transmission and acquisition.”
Dr. Larry Corey discussed why COVID vaccine Phase 3 trials focused on finding out if the vaccines reduced severe disease and didn’t measure transmission.
Dr. Larry Corey commented on the limited data about whether COVID vaccines prevent transmission.
Dr. Steve Pergam shared the importance of COVID-19 prevention measures for cancer patients.
Dr. Josh Schffer emphasized why it’s important to understand if COVID-19 vaccines prevent asymptomatic infections and transmissions.
Dr. Larry Corey commented on the diverse populations that were enrolled in the Moderna vaccine study.
Dr. Larry Corey underscored the benefit of COVID vaccines.
Dr. Josh Hill shared guidance for cancer patients and the COVID-19 vaccine.
The New Yorker gave updates on vaccine trials and the first vaccines to get emergency approval.
Dr. Josh Hill shared insight into the CDC’s new guidelines around quarantining after exposure to COVID-19.
Dr. Larry Corey spoke about the challenge of continuing to test some COVID vaccines, even as effective ones emerge.
Dr. Larry Corey characterized the latest data on Moderna’s COVID-19 vaccine candidate.
Dr. Larry Corey outlined a new plan to test if COVID-19 vaccines prevent infection.
Dr. Josh Schiffer authored an opinion piece urging Americans to take proper COVID-19 measures.
Dr. Larry Corey summarized the role Fred Hutch and the COVID-19 Prevention Network is playing during the pandemic.
Dr. Josh Schiffer detailed why the MLS may face more COVID-19 related cancellations.
Dr. Steve Pergam stressed the need for families to rethink holiday gatherings during the COVID-19 pandemic.
Dr. Larry Corey reflected on the speed of COVID-19 vaccine development.
Dr. Steve Pergam underscored the importance of taking COVID-19 precautions during the holidays.
Dr. Larry Corey touted the expertise Fred Hutch brings to coordinate COVID-19 vaccine trials.
Dr. Larry Corey reflected on full enrollment in the first Phase 3 vaccine trial.
Dr. Larry Corey discussed how the COVID-19 Prevention Trials Network has supported enrolling diverse populations into COVID-19 vaccine trials.
In an op-ed piece, Dr. Josh Schiffer suggested COVID-19 strategies can be flawed but still effective in reducing transmission.
Drs. Shelly Karuna and Larry Corey commented on the potential of monoclonal antibodies to treat and prevent COVID-19.
Dr. Steve Pergam described how the COVID-19 pandemic could impact other infections.
Dr. Larry Corey discussed the importance of conducting vaccine trials to the highest scientific standards.
Dr. Larry Corey discussed the purpose of CoVPN’s national ad campaign.
Dr. Keith Jerome discussed the importance of his new paper showing a 90% reduction of latent herpes virus.
Dr. Josh Schiffer provided outside commentary on a new study looking at a COVID-19 superspreading event in Boston.
Dr. Keith Jerome discussed his new study showing how gene editing removed 90% of herpes in mice.
Dr. Josh Schiffer described the role T-cells play in COVID-19 immune responses.
Dr. Larry Corey commented on how discussions are underway to include pregnant women and children in COVID-19 vaccine trials.
Dr. Steve Pergam raised concerns about how unnecessary COVID-19 testing could lead to negative behaviors.
A profile of Dr. Larry Corey and his role leading operations for the CoVPN.
Dr. Josh Schiffer described how to prevent COVID-19 superspreader events
Dr. Josh Schiffer shot down the idea of achieving natural herd immunity for COVID-19.
Dr. Steve Pergam raised concerns over MLS matches resuming.
Dr. Josh Schiffer emphasized the importance of “superspreader” events and COVID-19.
Kaiser Health News explored issues of vaccine efficacy in obese individuals, quoting Dr. Larry Corey.
Dr. Larry Corey explained aspects of participating in a COVID-19 vaccine trial.
Dr. Steve Pergam described the importance of getting flu shots, especially for protecting babies, older people and others with compromised immune systems.
Dr. Steve Pergam expressed concerns over COVID-19 testing and the impact on underrepresented populations.
Dr. Larry Corey emphasized the need for COVID vaccine data in pregnant women to find what is the safest vaccine for them.
Dr. Larry Corey explained CoVPN’s focus on including people at most risk for COVID-19 in the vaccine trials, specifically minorities and people with comorbidities.
Dr. Larry Corey discussed CoVPN trial enrollment goals in terms of reaching a diverse, multigenerational population.
Dr. Joshua Schiffer predicted what may happen if the U.S. tries to achieve herd immunity without a COVID-19 vaccine.
Dr. Steve Pergam weighed in on what we can do now to slow COVID-19, emphasizing physical distancing measures, PPE, test and tracing plans and masking.
Keith Jerome’s antibody work and antibody study results from the Fred Hutch campus are discussed.
Dr. Larry Corey’s comments saying a vaccine that is safe and works in at least 50% of people would be viable are discussed.
Dr. Steve Pergam shares tips to reduce the infection risk of COVID-19.
Dr. Larry Corey is mentioned for comments on the CoVPN registry, and the call for diverse trial participants.
Comedian Joel McHale spoke about his conversations on COVID-19 with Dr. Joshua Schiffer.
Dr. Larry Corey discussed how building the HIV trial network laid the foundation for CoVPN.
Dr. Joshua Schiffer commented on the trend of younger people getting COVID-19 and their risks.
The CoVPN announcement is covered by KING 5.
Dr. Larry Corey discussed the CoVPN network, how the vaccine trials will be run and his role in the program.
Dr. Larry Corey discussed how the CoVPN trial network will work and the goals of the program.
Forbes covered the CoVPN announcement and Fred Hutch’s role in the network of clinical trials.
Dr. Larry Corey commented on the role Fred Hutch will take in developing coronavirus vaccines, building off of work with HIV vaccines.
CNN covered the announcement of the CoVPN network, of which Fred Hutch will serve as the coordination center and Dr. Larry Corey as the lead.
Dr. Steve Pergam commented on the restarting of professional sports in July, reinforcing that it may be necessary to stop if COVID-19 cases rise.
Dr. Keith Jerome and Trevor Bedford explained the rise in positive COVID-19 tests, indicating a rise in infections rather than false positives.
Dr. Catherine Liu commented on COVID-19 and cancer patients, and the risk for more severe infection.
Dr. Larry Corey explained ‘Operation Warp Speed’ for developing COVID-19 vaccines, and the safety and efficacy standards of the program.
Dr. Steve Pergam weighed in on the potential impact of reopening restaurants, loosening other restrictions, and protests on COVID-19 infection rates.
Dr. Joshua Schiffer’s new review paper, with co-authors from Fred Hutch and UW, suggesting that an early test and treat strategy is the best way to control COVID-19, is covered.
A review article by Dr. Joshua Schiffer on ways to keep COVID-19 from getting out of control again is covered, highlighting the need for widespread testing and treatment early in diagnosis.
Dr. Joshua Schiffer’s new article emphasizing the need for widespread testing and early treatment for COVID-19 is discussed.
Dr. Steve Pergam weighed in on the risks of starting up the NBA season during COVID-19.
Dr. Larry Corey discussed COVID-19 vaccine trials and the challenges involved.
Dr. Larry Corey explained the complexities of COVID-19 vaccine trial setup and development.
Dr. Larry Corey discussed COVID-19 vaccine trials, the timelines, and how they will be structured.
Dr. Larry Corey and Dr. John Mascola’s webinar on COVID-19 vaccine development is quoted, specifically that vaccine development will require coordination from all industries.
A Fred Hutch webinar featuring Dr. Larry Corey and Dr. John Mascola of NIAID on COVID-19 vaccine development is recapped by GeekWire.
Dr. Joshua Schiffer weighed in on the safety of travel during the COVID-19 pandemic, and possible ways to keep infection risk low.
Dr. Steve Pergam commented on the need for public health to be driven by science and the value of the CDC.
Dr. Larry Corey is quoted on COVID-19 vaccine development progress.
Dr. Joshua Schiffer weighed in on the possibility of reinfection with COVID-19.
Dr. Larry Corey suggested potential timeframes for the development of a COVID-19 vaccine.
Dr. Larry Corey discussed the current status of COVID-19 vaccine trials.
Dr. Joshua Schiffer weighed in on the possibility of reinfection with COVID-19, saying more research is needed.
Dr. Larry Corey is quoted for the announcement of COVID-19 vaccine trials.
Bloomberg cited the CovidWatch study as one of the ways Amazon is working to stop COVID-19.
Dr. Larry Corey explained COVID-19 vaccine strategy and the current status of research around COVID-19 in this video interview with Science.
Dr. Steve Pergam commented on the shutdown of SCAN by the FDA.
Dr. Keith Jerome discussed COVID-19 virology, the possibility of reinfection, and transmission.
The Covidwatch study is profiled, with Dr. Michael Boeckh explaining the study goals.
Dr. Joshua Schiffer commented on the feasibility of staying safe from COVID-19 in large group gatherings such as concerts.
KIRO 7 covered the CovidWatch program, led by Dr. Michael Boeckh, which aims to better understand COVID-19.
Dr. Larry Corey discussed COVID-19 vaccine development and clinical trials.
Dr. Larry Corey commented on COVID-19 vaccine trials and strategy.
Business Insider referenced an editorial piece co-written by Drs. Larry Corey, Anthony Fauci and other experts on COVID-19 vaccine development.
The SCAN initiative is profiled by Gates Notes, mentioning Fred Hutch as a partner.
The SCAN initiative and Gates Notes article on the program are discussed.
Dr. Larry Corey’s co-authored editorial in Science, explaining a roadmap to a COVID-19 vaccine and calling for a variety of approaches and collaboration, is discussed.
The Science piece co-authored by Drs. Larry Corey, Anthony Fauci, Francis Collins and John Mascola is cited.
Dr. Larry Corey is quoted on the need for collaboration and multiple COVID-19 vaccines, in relation to the release of a co-authored piece on COVID-19 vaccine development in Science.
GeekWire featured Dr. Larry Corey’s Science perspective, co-authored with Drs Anthony Fauci, John Mascola and Francis Collins, on proposed COVID-19 vaccine plans.
KOMO profiled the COVIDWatch study led by Dr. Michael Boeckh to track COVID-19 in the population.
Dr. Larry Corey is discussed along with the co-authors Drs. Anthony Fauci, John Mascola and Francis Collins, on a Science perspective piece on the development of a COVID-19 vaccine.
Dr. Keith Jerome is quoted on the impact that early physical distancing measures had in lowering COVID-19 rates in Washington.
STAT covered the new COVIDWatch study and partnership with Amazon, aimed at learning more about COVID-19’s infection rate and if infection confers immunity.
Dr. Steve Pergam criticized those neglecting to follow physical distancing restrictions.
Dr. Josh Schiffer explained the complexity of COVID-19 immune response and variability across patients.
Dr. Steve Pergam discussed the importance of early detection of COVID-19 in Washington’s virus response.
Dr. Larry Corey weighed in on the use of HIV ARV’s as potential treatments for COVID-19.
Dr. Joshua Schiffer commented on a new COVID-19 patient registry to improve research efforts.
Dr. Joshua Schiffer is quoted on the use of hydroxychloroquine for COVID-19 treatment and the lack of understanding of its impact.
Drs. Tom Lynch and Larry Corey recalled the start of the COVID-19 epidemic and discussed Fred Hutch’s efforts to track and control the virus along with other notable Seattle companies.
GeekWire covered a new Fred Hutch study, Covidwatch, focused on those most at risk to get COVID-19, to help us better understand characteristics of the virus.
Drs. Larry Corey and Jesse Bloom discussed new COVID-19 antibody tests and research on neutralizing antibodies
Larry Corey provided context to a new study from Fred Hutch and UW suggesting Washington state has successfully lowered COVID-19 infections through physical distancing measures.
A study from Fred Hutch researchers on the use of ventilators in COVID-19 patients is cited.
Dr. Steve Pergam commented on the increased susceptibility for COVID-19 within cancer patients, and how oncologists should prepare.
Dr. Steve Pergam, along with other first responders in the Seattle area, published a piece on the COVID-19 pandemic and outbreaks in Washington.
Drs. Keith Jerome and Larry Corey explained work on blood tests for CoV-2 antibodies and the need for a vaccine.
Dr. Steve Pergam’s comments on how COVID-19 compares to the flu are included.
GeekWire covered Dr. Steve Pergam’s live COVID-19 Q&A, highlighting ways to stay safe but social.
Dr. Gary Lyman and Dr. Michael Boeckh discussed patient care and safety during COVID-19, and the Cancer Care COVID-19 registry.
Dr. Larry Corey commented on the quick development of potential vaccines and vaccine trials for COVID-19.
Dr. Larry Corey explained how the Seattle scientific community is stepping up to tackle COVID-19.
Dr. Kristin Anderson wrote about the researchers in Seattle who are working together to study and combat COVID-19, including Drs. Keith Jerome, Alex Greninger and Trevor Bedford.
Dr. Joshua Schiffer and Bryan Mayer discussed viral load variability in patients and what that could mean for COVID-19.
Drs. Steve Pergam and Masumi Ueda gave expert advice on treating cancer patients during the COVID-19 pandemic.
Dr. Steve Pergam called for more scientific involvement in decisions around COVID-19 containment.
Dr. Steve Pergam gave insight on the risk of cancer patients for COVID-19 infection.
Dr. Steve Pergam provided crucial advice on social distancing and the role it plays in preventing COVID-19 spread.
Dr. Steve Pergam gave Healio in depth advice to cancer patients to protect themselves from COVID-19.
Dr. Keith Jerome’s COVID-19 test kit and the development of UW’s testing facilities are discussed.
Dr. Steve Pergam is interviewed on COVID-19 and the risk to immunocompromised people.
Dr. Steve Pergam, an infectious disease expert, provided commentary on social distancing in light of COVID-19.
Dr. Steve Pergam provided expert commentary for cancer patients in light of COVID-19 and increased risk.
David Fredricks commented on outcomes of a large, international study showing that the microbiome predicts transplant success.
Dr. Steve Pergam comments on COVID-19 risk for cancer patients.
Dr. Steve Pergam is quoted on his advice for cancer patients in light of increased risk for COVID-19.
Seattle Flu Study is profiled, delving into Drs. Keith Jerome, Helen Chu and Trevor Bedford’s research on COVID19 genetic analysis and vaccine development.
Virologist Dr. Keith Jerome’s COVID-19 testing kit is discussed, along with Trevor Bedford’s computational analysis of COVID-19 spread.
Dr. Keith Jerome, a virologist, provided commentary on his new COVID-19 testing kit at UW Medicine.
Infectious disease expert Dr. Steve Pergam comments on what people with HIV need to know about COVID-19
Dr. Steve Pergam, an infectious disease expert, provided insight on COVID-19 risk for cancer patients.
Dr. David Fredricks, a microbiome researcher, provided expert commentary on vaginal microbiota transplantation.
Dr. David Fredricks, a microbiome researcher, provided expert commentary on vaginal microbiota transplantation.
Fred Hutch virologist Dr. Keith Jerome provided expert commentary about the second person who reportedly has been cured of HIV.
Fred Hutch virologist Dr. Keith Jerome provided expert commentary about the second person who reportedly has been cured of HIV.
Fred Hutch virologist Dr. Keith Jerome provided context around news of the second person who reportedly has been cured of HIV. He commented, “Now there’s not one, but two people that others living with HIV can look toward for encouragement.”
Fred Hutch virologist Dr. Keith Jerome provided context around news of the second person who reportedly has been cured of HIV. He commented, “Now there’s not one, but two people that others living with HIV can look toward for encouragement.”
Dr. Keith Jerome is featured in a story of research progress in treating herpes. He explains how his work with the gene editing tool – a class of enzymes called meganucleases – is showing more success in getting rid of the virus.
Dr. Keith Jerome is featured in a story of research progress in treating herpes. He explains how his work with the gene editing tool – a class of enzymes called meganucleases – is showing more success in getting rid of the virus.
Fred Hutch researcher Drs. Keith Jerome, Hans-Peter Kiem and Michael Louella, who coordinates the research group’s Community Advisory Board, provide expert comments on the importance of community engagement in HIV research.
Fred Hutch researcher Drs. Keith Jerome, Hans-Peter Kiem and Michael Louella, who coordinates the research group’s Community Advisory Board, provide expert comments on the importance of community engagement in HIV research.
Fred Hutch researcher Dr. Steve Pergam is featured as GeekWire’s ‘Geek of the Week’. Dr. Pergam is an associate member of the Vaccine and Infectious Disease Division at Fred Hutch.
Fred Hutch researcher Dr. Steve Pergam is featured as GeekWire’s ‘Geek of the Week’. Dr. Pergam is an associate member of the Vaccine and Infectious Disease Division at Fred Hutch.
Fred Hutch researcher Dr. Steve Pergam comments on cannabis use among cancer patients.
Fred Hutch researcher Dr. Steve Pergam comments on cannabis use among cancer patients.
This segment, which aired on the eve of World AIDS Day, covers local and global HIV vaccine trials led by Fred Hutch. It includes interviews with Drs. Janine Maenza, Larry Corey and an HIV study vaccine participant.
This article features a recent study by Fred Hutch Drs. Dan Reeves and Josh Schiffer that shows that a majority of the HIV-infected cells that persist in HIV-infected individuals even during suppressive antiretroviral therapy (ART) originate from cellular proliferation, not viral replication.
This article features a recent study by Fred Hutch Drs. Dan Reeves and Josh Schiffer that shows that a majority of the HIV-infected cells that persist in HIV-infected individuals even during suppressive antiretroviral therapy (ART) originate from cellular proliferation, not viral replication.
Dr. Keith Jerome, a virologist at Fred Hutch, co-authored a 2016 study about gene editing in herpes-infected mice. “His is the first study to show that gene-editing technology can reach the latent virus in a nerve cell, and the first to use that technology to damage some of the virus’ DNA,” according to a Smithsonian.com article on this and other efforts to combat the virus in humans.
Dr. Keith Jerome, a virologist at Fred Hutch, co-authored a 2016 study about gene editing in herpes-infected mice. “His is the first study to show that gene-editing technology can reach the latent virus in a nerve cell, and the first to use that technology to damage some of the virus’ DNA,” according to a Smithsonian.com article on this and other efforts to combat the virus in humans.
Profile of Dr. Larry Corey and his research on how immunotherapy could be used to attack HIV and other viruses
Profile of Dr. Larry Corey and his research on how immunotherapy could be used to attack HIV and other viruses
Article about a $2.6 million grant from Gilead Sciences to Dr. Larry Corey for HIV-cure research
Article about a $2.6 million grant from Gilead Sciences to Dr. Larry Corey for HIV-cure research
Second in a two-part series about Fred Hutch's HIV vaccine research in South Africa quotes Dr. Larry Corey and Julie McElrath, among others
Quotes Dr. David Fredricks, a microbiologist at the Hutch, in an article about how the vaginal microbiome might contribute to HIV risk
Second in a two-part series about Fred Hutch's HIV vaccine research in South Africa quotes Dr. Larry Corey and Julie McElrath, among others
Second in a two-part series about Fred Hutch's HIV vaccine research in South Africa quotes Dr. Larry Corey and Julie McElrath, among others
Quotes Dr. David Fredricks, a microbiologist at the Hutch, in an article about how the vaginal microbiome might contribute to HIV risk
Article covers upcoming HIV Vaccine Trials Network large-scale trial, set to begin later this year, and quotes Dr. Larry Corey, president and director emeritus at Fred Hutch and principal investigator of the HVTN
Article covers upcoming HIV Vaccine Trials Network large-scale trial, set to begin later this year, and quotes Dr. Larry Corey, president and director emeritus at Fred Hutch and principal investigator of the HVTN
Editorial by Fred Hutch HIV vaccine researcher and Director Emeritus Dr. Larry Corey and Nobel laureate Dr. David Baltimore of the California Institute of Technology
Editorial by Fred Hutch HIV vaccine researcher and Director Emeritus Dr. Larry Corey and Nobel laureate Dr. David Baltimore of the California Institute of Technology
Fred Hutch virologist Dr. Larry Corey was interviewed about being featured in a VICE documentary on HBO, "Countdown to Zero," about the search for an HIV vaccine and cure.
Quotes Fred Hutch HIV vaccine researcher Dr. Larry Corey
Fred Hutch virologist Dr. Larry Corey was interviewed about being featured in a VICE documentary on HBO, "Countdown to Zero," about the search for an HIV vaccine and cure.
Quotes Fred Hutch HIV vaccine researcher Dr. Larry Corey